[1]
|
Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. https://doi.org/10.3322/caac.21660
|
[2]
|
林宇挺, 熊海林. II~III期结直肠癌中Vasohibin-1的表达及复发转移预后分析[J]. 中国肿瘤外科杂志, 2021, 13(5): 484-488.
|
[3]
|
田剑波, 温艳, 杨卓煜, 郑亚迪, 吴峥, 等. 全球结直肠癌筛查指南及共识质量评价[J]. 中华流行病学杂志, 2021, 42(2): 248-257.
|
[4]
|
Abbas, M., Kassim, S.A., Wang, Z.-C., Shi, M., Hu, Y., et al. (2020) Clinical Evaluation of Plasma Co-agulation Parameters in Patients with Advanced-Stage Non-Small Cell Lung Cancer Treated with Palliative Chemothera-py in China. International Journal of Clinical Practice, 74, e13619. https://doi.org/10.1111/ijcp.13619
|
[5]
|
姜巧丽, 樊浩然, 赵东亮. 血浆D-二聚体和纤维蛋白原对结直肠癌患者手术后生存状况的预测效果[J]. 四川生理科学杂志, 2020, 42(2): 147-150.
|
[6]
|
Repetto, O. and De Re, V. (2017) Coagulation and Fibrinolysis in Gastric Cancer. An-nals of the New York Academy of Sciences, 1404, 27-48. https://doi.org/10.1111/nyas.13454
|
[7]
|
王焱, 华向东. 结直肠癌患者D-二聚体检测水平及其临床意义[J]. 中国临床医生杂志, 2022, 50(1): 83-85.
|
[8]
|
姜烜星, 金永合, 王涛. D-二聚体水平与晚期结直肠癌化疗者预后的相关性[J]. 中国肛肠病杂志, 2019, 39(8): 18-19.
|
[9]
|
Blackwell, K., Hurẃitz, H., Liebérman, G., Novotny, W., Snyder, S., et al. (2004) Circulating D-Dimer Levels Are Better Predictors of Overall Survival and Disease Progression than Carcinoembryonic Antigen Levels in Pa-tients with Metastatic Colorectal Carcinoma. Cancer, 101, 77-82. https://doi.org/10.1002/cncr.20336
|
[10]
|
Li, H., Zhao, S., Jing, Z., Li, J., Yang, S., et al. (2019) Combination of D-Dimer and Carcinoembryonic Antigen Levels as a Predictive and Prognostic Biomarker in Advanced Colorectal Cancer Patients. Journal of Cellular Biochemistry, 120, 8086-8092. https://doi.org/10.1002/jcb.28087
|
[11]
|
Liu, C., Ning, Y., Chen, X. and Zhu, Q. (2020) D-Dimer Level Was Associated with Prognosis in Metastatic Colorectal Cancer: A Chinese Patients Based Cohort Study. Medicine, 99, e19243.
https://doi.org/10.1097/MD.0000000000019243
|
[12]
|
Moik, F., Posch, F., Grilz, E., Scheithauer, W., Pabinger, I., et al. (2020) Haemostatic Biomarkers for Prognosis and Prediction of Therapy Response in Patients with Metastatic Col-orectal Cancer. Thrombosis Research, 187, 9-17.
https://doi.org/10.1016/j.thromres.2020.01.002
|
[13]
|
Yamamoto, M., Yoshinaga, K., Matsuyama, A., Iwasa, T., Osoegawa, A., et al. (2012) Plasma D-Dimer Level as a Mortality Predictor in Patients with Advanced or Recurrent Col-orectal Cancer. Oncology, 83, 10-15.
https://doi.org/10.1159/000338329
|
[14]
|
Zhu, L., Liu, B., Zhao, Y., Liu, L., Yang, C., et al. (2014) High Levels of D-Dimer Correlated with Disease Status and Poor Prognosis of Inoperable Metastatic Colorectal Cancer Patients Treated with Bevacizumab. Journal of Cancer Research and Therapeutics, 10, 246-251. https://doi.org/10.4103/0973-1482.151451
|
[15]
|
赵爽爽, 许青. D-二聚体对晚期结直肠癌患者预后的影响[J]. 现代肿瘤医学, 2016, 24(24): 3953-3956.
|
[16]
|
薛丽英, 南景龙, 李卉, 东丽, 蔡智慧, 等. 血浆D-二聚体水平与复发转移性结直肠癌患者预后的相关性[J]. 中华实用诊断与治疗杂志, 2014, 28(3): 254-255+258.
|
[17]
|
Ojima, Y., Harano, M., Sumitani, D., Yoshimitsu, M. and Okajima, M. (2021) Prognostic Value of Preoperative Carcinoembryonic Antigen and D-Dimer Concentrations in Patients Undergoing Curative Resection for Colorectal Cancer. Surgery Today, 51, 1108-1117. https://doi.org/10.1007/s00595-020-02187-0
|
[18]
|
Hong, T., Shen, D., Chen, X., Wu, X. and Hua, D. (2017) Preoperative Plasma Fibrinogen, But Not D-Dimer Might Represent a Prognostic Factor in Non-Metastatic Colorectal Cancer: A Prospective Cohort Study. Cancer Biomarkers, 19, 103-111. https://doi.org/10.3233/CBM-160510
|
[19]
|
Sawicki, T., Ruszkowska, M., Danielewicz, A., Niedźwiedzka, E., Arłukowicz, T., et al. (2021) A Review of Colorectal Cancer in Terms of Epidemiology, Risk Factors, Development, Symptoms and Diagnosis. Cancers, 13, Article No. 2025. https://doi.org/10.3390/cancers13092025
|
[20]
|
杨景婷. 恶性肿瘤高凝状态相关的血液参数改变及抗凝治疗的意义[D]: [硕士学位论文]. 天津: 天津医科大学, 2018.
|
[21]
|
Traby, L., Puhr, H.C., Kollars, M., Steinbrecher, O., Prager, G., et al. (2020) Effects of Chemotherapy on Extracellular Vesicles and Coagulation Activation in Advanced Colorectal Cancer Patients. Research and Practice in Thrombosis and Haemostasis, 4, 177-178.
|
[22]
|
汪敏, 于鹏跃, 王言, 宋燕珂, 李峣, 等. 外周血凝血指标、血小板计数和NLR检测对恶性肿瘤患者治疗前机体凝血状态的评估价值[J]. 吉林大学学报(医学版), 2022, 48(1): 203-210.
|
[23]
|
Xu, W., Yang, M., Zhao, C., Wang, P., Deng, K., et al. (2021) Massive Spondylectomy for Metastatic Spinal Cord Compression from Non-Small-Cell Lung Cancer with Local Failure after Radiotherapy. Global Spine Jour-nal, 11, 549-555. https://doi.org/10.1177/2192568220919099
|
[24]
|
Kanehira, D., Kusakabe, M., Shimizu, S., Shimizu, J., Irikuchi, J., et al. (2021) Reliability and Validity of D-Dimer Monitoring for Pulmonary Thromboembolism in Patients with Unresectable, Advanced or Recurrent Colorectal Cancer Treated with Bevacizumab. Molecular and Clin-ical Oncology, 15, Article No. 165.
https://doi.org/10.3892/mco.2021.2327
|
[25]
|
Chen, W., Shan, B., Zhou, S, Yang, H. and Ye, S. (2022) Fibrino-gen/Albumin Ratio as a Promising Predictor of Platinum Response and Survival in Ovarian Clear Cell Carcinoma. BMC Cancer, 22, Article No. 92.
https://doi.org/10.1186/s12885-022-09204-0
|
[26]
|
刘艳, 戴永洲, 姚文亿, 刘兰涛, 李秋营, 等. D-二聚体与胰腺癌患者的生存期及预后的相关性分析[J]. 当代医学, 2022, 28(3): 104-108.
|
[27]
|
Ding, R., Chen, Z., He, M., Cen, H., Liu, Z., et al. (2022) Application Value of Combined Detection of NLR, PNI, D-Dimer, CD3+ T Lymphocytes, and CEA in Colorectal Cancer Screening. Disease Markers, 2022, Article ID: 7913025.
https://doi.org/10.1155/2022/7913025
|
[28]
|
Giaccherini, C., Verzeroli, C., Russo, L., Gamba, S., Tartari, C.J., et al. (2022) Thrombin Generation and D-Dimer for Prediction of Disease Progression and Mortality in Patients with Meta-static Gastrointestinal Cancer. Cancers, 14, Article No. 4347. https://doi.org/10.3390/cancers14184347
|
[29]
|
Odaira, N., Yoshino, M., Kurematsu, N., Sasaki, N., Tagawa, C., et al. (2019) [Risk Factors of Thromboembolism in Colorectal Cancer Patients Receiving Combination Chemotherapy with Bevacizumab]. Gan to Kagaku ryoho. Cancer & Chemo-therapy, 46, 1531-1535. (In Japanese)
|